Replies to post #167729 on Cytodyn Inc (CYDY)

[Hookmeistr]

Thank you for answering this as it also answers my question on the same issue. I wasn't aware that it's typically standard practice to provide fair distribution of patients by age.

In CD12 everything was not proper , somehow..

Yeah, "somehow"....cough cough....wonder how that might have happened. Probably zero chance the deck was stacked against us, right? (mad emoji here)

Also, I previously brought up the issue with Blood type A vs Blood type O. Type A being found to have higher rate of mortality than type O. It would be nice if this was also factored into the patient distribution but in doing so it could potentially cause serious delays in finding qualified participants in a timely manner. Dr Kelly responded as follows:

xxxxxxx,

Thank you for reaching out to us.

As you know, CytoDyn welcomes dialogue with shareholders, and we pride ourselves on the transparency we provide to investors and the market.

However, as a public company, CytoDyn has “fair disclosure” obligations under Regulation FD, 17 CFR Part 243. The company is prohibited by federal law from disclosing material non-public information except in a public disclosure or under specifically enumerated conditions. Selective disclosure of material non-public information would violate our Regulation FD obligations and expose CytoDyn to potential litigation and regulatory actions.

We take seriously our obligation to protect material non-public information. Therefore we provide investors information in various public forums, including securities filings, press releases, and investor calls. We try to answer all questions on the investor’s conference call, but we can’t always promise every question will be answered despite our best intentions.

We invite you to submit additional questions in a publicly available forum, such as an investors call.

Best,
Scott


Scott A. Kelly, MD
Chief Medical Officer, Chairman of the Board, Head of Business Development
CytoDyn Inc. (www.cytodyn.com)
1111 Main Street, Suite 660
Vancouver, Washington 98660
E-mail: [e-mail]
Office: [phone]
Facsimile: [phone]
Mobile: [phone]